MedPath

To Study Effect OF GOPIYUSH CAPSULE In PULMONARYTUBERCULOSIS (TB) along with Conventional Medicatio

Phase 4
Conditions
Health Condition 1: A150- Tuberculosis of lung
Registration Number
CTRI/2023/08/056878
Lead Sponsor
Pitambari Products PVT LTD
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Newly diagnosed cases of Pulmonary Tuberculosis confirmed by sputum smear and culture or positive for AFB

2. Age group 18-50

3. Both Genders

Exclusion Criteria

1.Patients which are sero-positive ,

2.HBA1C should be less than 8

3.Extra pulmonary tuberculosis

4.Patient diagnosed with MDR pulmonary tuberculosis.

5.Pulmonary tuberculosis with H/O treatment defaulter

6.Patient having history of Steroidal treatments.

7.Patients on Immunosuppressant

8.Liver diseases

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Add on efficacy of Gopiyush Capsules with repsect to Conversion of Sputum Negativity along with remarkable reducion in Cough and weight gainTimepoint: Final assessment at the end of 3 months
Secondary Outcome Measures
NameTimeMethod
Improvement in General Health Conditions like body weight,digestion,BalaTimepoint: After 3 Months
© Copyright 2025. All Rights Reserved by MedPath